Accelerate diagnostics announces collaboration for the use of the arc™ system in combination with bruker´s maldi biotyper®

Working together to bring rapid, automated microbial identification directly from positive blood culture samples tucson, ariz. , nov. 27, 2023 /prnewswire/ -- accelerate diagnostics, inc. (nasdaq: axdx) an innovator of rapid in vitro diagnostics in microbiology, announced the signing of a collaboration and quality agreement with bruker corporation (nasdaq: brkr), the provider of the market-leading maldi biotyper system for microbial identification.
AXDX Ratings Summary
AXDX Quant Ranking